Driven by reduced insulin signalling and/or insulin resistance in adipose tissue, liver, and skeletal muscle, pathological changes in these non-cardiac tissues contribute to the development and progression of diabetic cardiomyopathy (Figure 1). The gene discussed is INS; the disease is diabetic cardiomyopathy.